NCT01515397View on ClinicalTrials.gov

Comparison of Two Gelatine Solutions

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Hypovolemia
Interventions
DRUG

Gelofusine balanced

Gelofusine balanced combined with Sterofundin ISO

DRUG

Gelofusine 4%

Gelofusine 4% combined with NaCl 0.9%

Trial Locations (2)

52074

Universitätsklinikum Aachen, Klinik für Anästhesiologie, Aachen

60590

Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie, Universitätsklinikum Frankfurt/Main, Frankfurt am Main

All Listed Sponsors
lead

B. Braun Melsungen AG

INDUSTRY

NCT01515397 - Comparison of Two Gelatine Solutions | Biotech Hunter | Biotech Hunter